FIELD: medicine.
SUBSTANCE: group of inventions relates specifically to oncology and therapy, and is intended for the treatment of non-naive advanced stage bile duct cancer. For the treatment of bile duct cancer, therapeutic agents containing an amount of a fluoropyrimidine-containing therapeutic agent and an amount of a crystallized binimetinib MEK inhibitor or a pharmaceutically acceptable salt thereof are administered to a patient in need over a period of time. These amounts together are effective in the treatment of cancer of the bile ducts.
EFFECT: use of the group of inventions provides for the treatment of advanced stage bile duct cancer that has been previously treated.
65 cl, 3 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMBINATIONS | 2017 |
|
RU2759669C2 |
| TETRAHYDROFOLATES IN COMBINATION WITH EGFR INHIBITORS | 2013 |
|
RU2619335C2 |
| APPLICATION OF ALLOPURINOL FOR TREATING PALMOPLANTAR ERYTHRODYSESTHESIA | 2007 |
|
RU2438673C2 |
| COMBINATION OF TRIFLURIDINE/TIPIRACIL HYDROCHLORIDE, ANTITUMOR PLATINUM COMPLEX, AND MODULATOR OF CONTROL POINTS OF IMMUNE RESPONSE | 2018 |
|
RU2778887C2 |
| METHODS OF TREATING PANCREATIC CANCER | 2011 |
|
RU2576609C2 |
| APPLICATION OF RAPAMYCIN DERIVATIVE | 2013 |
|
RU2665138C2 |
| APPLICATION OF RAPAMYCIN DERIVATIVE | 2013 |
|
RU2659725C2 |
| METHODS OF APPLYING (+)-1,4-DIHYDRO-7-[(3S, 4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(THIAZOLYL)-1,8-NAPHTHIRIDINE-3-CARBOXYLIC ACID FOR CANCER TREATMENT | 2006 |
|
RU2592231C2 |
| COMBINATION AND METHOD FOR PROPHYLAXIS OF BREAST CANCER | 2002 |
|
RU2322981C2 |
| CANCER MEDICAL TREATMENT | 2005 |
|
RU2325906C2 |
